Is the 0DTE premium-selling boom finally running out of steam? Or are premium sellers still holding the winning hand?

In this highly anticipated follow-up to one of our most popular episodes, Mark Longo and Dan Passarelli revisit the question: Should you stop selling 0DTE options? This time, they're armed with something they didn't have before—real intraday backtesting data.

Joining the program is Matt Amberson, Founder of ORATS, who brings years of options analytics expertise and a treasure trove of intraday options data to the discussion. Together they dive deep into:

The results of extensive 0DTE SPX backtesting
Why short strangles continue to outperform in many market environments
The surprising impact of trade timing on 0DTE profitability
Why selling premium near the open may be far superior to waiting until midday
The risks and rewards of short strangles versus iron condors
Double calendars and other alternatives for traders seeking defined risk
How ORATS built one-minute options data and intraday backtesting tools
Whether the new generation of single-name 0DTE options (NVDA, TSLA, MSFT and more) changes the game